Cerity Partners LLC Amgen Inc Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Cerity Partners LLC holds 395,273 shares of AMGN stock, worth $104 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

395,273

Previous 345,239 14.49%

Holding current value

$104 Million

Previous $108 Million 18.07%

% of portfolio

0.28%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $15.5 Million - $16.9 Million	50,034 Added 14.49%	395,273 $127 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $9.92 Million - $12.1 Million	-37,740 Reduced 9.85%	345,239 $108 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $31.3 Million - $37.8 Million	116,554 Added 43.75%	382,979 $109 Million
Q4 2023 Jan 26, 2024	BUY	$255.7 - $288.46 $5.99 Million - $6.76 Million	23,420 Added 9.64%	266,425 $76.7 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $8.14 Million - $10.1 Million	-37,221 Reduced 13.28%	243,005 $65.3 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $9.8 Million - $11.6 Million	45,720 Added 19.5%	280,226 $62.2 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $9.48 Million - $11.6 Million	41,976 Added 21.8%	234,506 $56.7 Million
Q4 2022 Feb 15, 2023	BUY	$229.03 - $291.01 $24 Million - $30.5 Million	104,702 Added 119.21%	192,530 $50.6 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $99,884 - $112,651	445 Added 0.51%	87,828 $19.8 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $11.9 Million - $13.2 Million	51,555 Added 143.9%	87,383 $21.3 Million
Q1 2022 Apr 25, 2022	BUY	$219.27 - $242.57 $586,327 - $648,632	2,674 Added 8.07%	35,828 $7.8 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.49 Million - $1.71 Million	7,511 Added 29.29%	33,154 $6.66 Million
Q3 2021 Oct 25, 2021	BUY	$212.27 - $248.7 $788,370 - $923,671	3,714 Added 16.94%	25,643 $5.45 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $56,059 - $62,193	240 Added 1.11%	21,929 $5.35 Million
Q1 2021 Aug 11, 2021	SELL	$221.91 - $258.6 $65,907 - $76,804	-297 Reduced 1.35%	21,689 $5.4 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $351,727 - $409,881	-1,585 Reduced 6.72%	21,986 $5.47 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $211,403 - $251,743	977 Added 4.32%	23,571 $5.42 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $987,407 - $1.1 Million	4,208 Added 22.89%	22,594 $5.74 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $152,709 - $187,395	772 Added 4.38%	18,386 $4.34 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $158,002 - $209,553	867 Added 5.18%	17,614 $3.57 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $49,005 - $62,988	259 Added 1.57%	16,747 $4.04 Million
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $479,847 - $574,956	2,756 Added 20.07%	16,488 $3.19 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $845,502 - $991,119	-5,072 Reduced 26.97%	13,732 $2.53 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $654,930 - $738,249	-3,621 Reduced 16.15%	18,804 $3.57 Million
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $214,972 - $250,941	1,205 Added 5.68%	22,425 $4.37 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $35,205 - $39,689	190 Added 0.9%	21,220 $4.4 Million
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $233,798 - $262,606	-1,408 Reduced 6.28%	21,030 $3.88 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $200,096 - $233,838	-1,181 Reduced 5.0%	22,438 $3.83 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $42,703 - $47,713	253 Added 1.08%	23,619 $4.11 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $3.91 Million - $4.46 Million	23,366	23,366 $4.36 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Amgen Inc Transaction History